中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Jing-Fang MU)

1.Medication rules and mechanisms of treating chronic renal failure by Jinling medical school based on data mining, network pharmacology, and experimental validation.

Jin-Long WANG ; Wei WU ; Yi-Gang WAN ; Qi-Jun FANG ; Yu WANG ; Ya-Jing LI ; Fee-Lan CHONG ; Sen-Lin MU ; Chu-Bo HUANG ; Huang HUANG

China Journal of Chinese Materia Medica 2025;50(6):1637-1649

2.Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell

Bing-Tao MU ; Min-Fang GUO ; Jing-Wen YU ; Jia-Lei CAO ; Feng-Jun YANG ; Si-Wei JIA ; Qing SU ; Tao MENG ; Cun-Gen MA ; Jie-Zhong YU ; Li-Juan SONG

Medical Journal of Chinese People's Liberation Army 2025;50(2):188-196

3.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

4.Effect of embryo cryostorage duration on pregnancy and obstetric outcomes in patients undergoing FET assisted reproduction

Haixia CHEN ; Tuo KUANG ; Fang LI ; Jing ZHANG ; Xiaohuan MU ; Yonghuan LYU ; Wenyan TIAN ; Xueru SONG ; Xiaohong BAI

Chinese Journal of Reproduction and Contraception 2025;45(1):59-66

5.Effect of embryo cryostorage duration on pregnancy and obstetric outcomes in patients undergoing FET assisted reproduction

Haixia CHEN ; Tuo KUANG ; Fang LI ; Jing ZHANG ; Xiaohuan MU ; Yonghuan LYU ; Wenyan TIAN ; Xueru SONG ; Xiaohong BAI

Chinese Journal of Reproduction and Contraception 2025;45(1):59-66

6.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

7.Stability study of umbilical cord mesenchymal stem cells formulation in large-scale production

Wang-long CHU ; Tong-jing LI ; Yan SHANGGUAN ; Fang-tao HE ; Jian-fu WU ; Xiu-ping ZENG ; Tao GUO ; Qing-fang WANG ; Fen ZHANG ; Zhen-zhong ZHONG ; Xiao LIANG ; Jun-yuan HU ; Mu-yun LIU

Acta Pharmaceutica Sinica 2024;59(3):743-750

8. Effect of FKBP38 protein on endometrial precancerous lesions and mechanism

Yun-Jing YAN ; Yun-Ping MU ; Shuai WANG ; Zi-Jian ZHAO ; Fang-Hong LI

Chinese Pharmacological Bulletin 2023;39(7):1320-1324

9. Effect of a novel phosphodiesterase type 5 inhibitor, CPD1, on paraquat-induced lung fibrosis in rats

Jie GAO ; Jian WU ; Jie GAO ; Jing ZHANG ; Jian WU ; Jian-Qin YANG ; Hao-Heng QIU ; Zi-Jian ZHAO ; Fang-Hong LI ; Yun-Ping MU

Chinese Pharmacological Bulletin 2023;39(6):1136-1142

10. Study on role of HDAC5 in P-gp expression in rats in high-altitude low oxygen environment and its effect on phenytoin sodium pharmacokinetics

Yi-Lan ZHAO ; Hong-Fang MU ; Xiao-Jing ZHANG ; Lin LUO ; Jia-Xin HE ; An-Peng ZHAO ; Rong WANG ; Yi-Lan ZHAO ; Lin LUO ; Shi-Ian FENG ; Jia-Xin HE ; Yi-Lan ZHAO ; Hong-Fang MU ; Xiao-Jing ZHANG ; Lin LUO ; Jia-Xin HE ; An-Peng ZHAO ; Rong WANG

Chinese Pharmacological Bulletin 2023;39(9):1740-1745

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO